Efficacy and safety of topical alprostadil cream for the treatment of female sexual arousal disorder (FSAD): A double-blind, multicenter, randomized, and placebo-controlled clinical trial

Journal of Sex and Marital Therapy

Volumn 29, Issue 5, 2003, Pages 329-344

  Padma Nathan, Harin ^a   Brown, Candace ^b   Fendl, Jane ^c   Salem, Shawki ^d   Yeager, James ^c   Harning, Ronald ^c  

^a Male Clinic   (United States)

^b University of Tennessee Campbell Clinic   (United States)

^c NexMed USA Inc   (United States)

^d Symbiance Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROSTAGLANDIN E1;

ANXIETY DISORDER; ARTICLE; BURNING SENSATION; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPAREUNIA; DYSPNEA; EDEMA; ELECTROCARDIOGRAM; ERYTHEMA; FEMALE; GENITAL SYSTEM; HEART PALPITATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; NAUSEA; PHASE 2 CLINICAL TRIAL; PRURITUS; PYURIA; RANDOMIZED CONTROLLED TRIAL; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SKIN MANIFESTATION; SKIN SENSITIVITY; TREATMENT OUTCOME; VAGINA DISEASE; VERTIGO;

ADMINISTRATION, CUTANEOUS; ADULT; ALPROSTADIL; ANALYSIS OF VARIANCE; COITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; PATIENT SATISFACTION; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS; VULVA;

EID: 0141840828     PISSN: 0092623X     EISSN: None     Source Type: Journal    
DOI: 10.1080/00926230390224710     Document Type: Article

References (31)

1. Baldwin, D., Bobes, J., Stein, D. J., Scharwachter, I., & Faure, M. (1999). Paroxetine in social phobia/social anxiety disorder: Randomized, double-blind, placebo-controlled study. British Journal of Psychiatry, 175, 120-126.
2. Basson, R. (2002). The complexities of female sexual arousal disorder: Potential role of pharmacotherapy. World Journal of Urology, 20, 119-126.
3. Basson, R., Berman, J., Burnett, A., Derogatis, L., Ferguson, D., Fourcroy, J., Goldstein, I., Graziottin, A., Heiman, J., Lann, E., Leiblum, S., Padma-Nathan, H., Rosen, R., Segraves, K., Taylor Segraves, R., Shabsigh, R., Sipski, M., Wagner, G., & Whipple, B. (2000). Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and classifications. Journal of Urology, 163, 888-893.
4. Basson, R., McInnes, R., Smith, M. D., Hodgson, G., & Koppiker, N. (2002). Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. Journal of Women's Health and Gender-based Medicine, 11, 367-377.
5. Becher, E. F., Bechara, & Casabe, A. (2001). Clitoral hemodynamic changes after a topical application of alprostadil. Journal of Sex & Marital Therapy, 27, 405-410.
6. Berman, J. R., Berman, L., & Goldstein, I. (1999). Female sexual dysfunction: Incidence, pathophysiology, evaluation, and treatment options. Urology, 54, 385-391.
7. Berman, J. R., Berman, L. A., Lin, H., Flaherty, E., Lahey, N., & Goldstein, I. (2001). Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. Journal of Sex & Marital Therapy, 27, 411-420.
8. Berman, L. A., Berman, J. R., Chhabra, S., & Goldstein, I. (2001). Novel approaches to female sexual dysfunction. Expert Opinion on Investigational Drugs, 10, 85-95.
9. Caruso, S., Intelisano, G., Lupo, L., & Agnello, C. (2001). Premenopausal women affected by sexual arousal disorder treated with sildenafil: A double-blind, crossover, placebo-controlled study. BJOG, 108, 623-628.
10. Derby, C. A., Araujo, A. B., Johannes, C. B., Feldman, H. A., & McKinlay, J. B. (2000). Measurement of erectile dysfunction in population-based studies: The use of a single question of self-assessment in the Massachusetts Male Aging Study. International Journal of Impotence Research, 12, 197-204.
11. Derogatis, L. R., Rosen, R., Leiblum, S., Burnett, A., & Heiman, J. (2002). The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women. Journal of Sex & Marital Therapy, 28, 317-330.
12. Duncan, L. E., Lewis, C., Jenkins, P., & Pearson, T. A. (2000). Does hypertension and its pharmacotherapy affect the quality of sexual function in women? American Journal of Hypertension, 13, 640-647.
13. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994). Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. Journal of Urology, 151, 54-61.
14. Goldstein, I., & Berman, J. R. (1998). Vasculogenic female sexual dysfunction: Vaginal engorgement and clitoral insufficiency syndromes. International Journal of Impotence Research, 10(Suppl. 2), S84-S90.
15. Heiman, J. R. (1980). Female sexual response patterns: Interaction of physiological, affective and contextual cues. Archives of General Psychiatry, 37, 1311-1316.
16. Heymann, R. E., Helfenstein, M., & Feldman, D. (2001). A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromylagia: An analysis of outcome measures. Clinical and Experimental Rheumatology, 19, 697-702.
17. Hickie, I. B., Wilson, A. J., Wright, J. M., Bennett, B. K., Wakefield, D., & Lloyd, A. R. (2000). A randomized, double-blind, placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. Journal of Clinical Psychiatry, 61, 643-648.
18. Islam, A., Mitchell, J., Rosen, R., Phillips, N., Ayers, C., Ferguson, D., & Yeager, J. (2001). Topical alprostadil in the treatment of female sexual arousal disorder: A pilot study. Journal of Sex & Marital Therapy, 27, 531-540.
19. Ito, T. Y., Trant, A. S., & Polan, M. L. (2001). A double-blind placebo-controlled study of ArginMax, a nutritional supplement for enhancement of female sexual function. Journal of Sex & Marital Therapy, 27, 541-549.
20. Laumann, E. O., Paik, A., & Rosen, R. C. (1999). Sexual dysfunction in the United States: Prevalence and predictors. Journal of the American Medical Association, 281, 537-544.
21. McVary, K. T., Polpalle, S., Riggi, S., & Pelham, R. W. (1999). Topical prostaglandin El SEPA gel for the treatment of erectile dysfunction. Journal of Urology, 162, 726-730.
22. Meston, C. M., & Heiman, J. R. (1998). Ephedrine-activated physiological sexual arousal in women. Archives of General Psychiatry, 55, 652-656.
23. Park, K., Goldstein, I., Andry, C., Siroky, M. B., Krane, R. J., & Azadzoi, K. M. (1997). Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. International Journal of Impotence Research, 9, 27-37.
24. Porst, H., Buvat, J., Meuleman, E., Michal, V., & Wagner, G. (1998). Intracavernosal Alprostadil Alfadex - an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study. International Journal of Impotence Research, 10, 225-231.
25. Rosen, R. C. (2000). Sexual pharmacology in the 21st century. Journal of Gender-Specific Medicine, 3, 45-52.
26. Rosen, R. C. (2002). Assessment of female sexual dysfunction: Review of validated methods. Fertility and Sterility, 77(Suppl. 4), S89-S93.
27. Rosen, R., Brown, C., Heiman, J., Leiblum, S., Meston, C., Shabsigh, R., Ferguson, D., & D'Agostino, R., Jr. (2000). The Female Sexual Function Index (FSFI): A multi-dimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy, 26, 191-208.
28. Rosen, R. C., Phillips, N. A., Gendrano, N. C. III, & Ferguson, D. (1999). Oral phentolamine and female sexual arousal disorder: A pilot study. Journal of Sex & Marital Therapy, 25, 137-144.
29. Snedecor, G., & Cochran, W. (1967). StatisticaI methods. Ames: Iowa State University.
30. Van Ameringen, M. A., Lane, R. M., Walker, J. R., Bowen, R. C., Chokka, P. R., Goldner, E. M., Johnston, D. G., Lavallee, Y. J., Nandy, S., Pecknold, J. C., Hadrava, V., & Swinson, R. P. (2001). Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study. American Journal of Psychiatry, 158, 275-281.
31. Williams, G., Abbou, C. C., Amar, E. T., Desvaux, P., Flam, T. A., Lycklama a Nijeholt, G. A., Lynch, S. F., Morgan, R. J., Muller, S. C., Porst, H., Pryor, J. P., Witzsch, U. K., Hall, M. M., Place, V. A., Spivack, A. P., Todd, L. K., & Gesundheit, N. (1998). The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners. British Journal of Urology, 82, 847-854.